In the Spotlight | What Is in SA's Vaccination Schedule and How Does It Measure Up?

South Africa maintains a robust Expanded Programme on Immunisation (EPI) schedule, offering free vaccines against twelve of the thirteen childhood diseases recommended for universal vaccination by the World Health Organization (WHO). Governed primarily by the National Health Act 61 of 2003 and the Children's Act 38 of 2005, the schedule has seen significant advancements, including the recent introduction of rubella vaccination and a single-dose HPV strategy. While the public sector provides comprehensive coverage, the private sector offers additional optional vaccines. Despite the comprehensiveness of the schedule, challenges persist, notably falling vaccination rates and ongoing legal debates surrounding consent and mandatory vaccination, particularly in the context of the Children's Act and workplace policies.

South Africa's commitment to public health is significantly underscored by its comprehensive vaccination programme, a cornerstone in the nation's strategy to combat preventable diseases. The Expanded Programme on Immunisation (EPI) in South Africa serves as the primary mechanism for delivering essential vaccines to children across the country, aiming to safeguard the health of its youngest citizens and, by extension, the broader community. This programme has evolved considerably since its inception, aligning with global health recommendations and adapting to local epidemiological needs.

For legal professionals, understanding the intricacies of South Africa's vaccination schedule is crucial. It touches upon various legal domains, including health law, children's rights, administrative law, and increasingly, labour law. The legal framework supporting these public health initiatives, the specific vaccines included, and how the national schedule compares to international best practices are all vital considerations for advising clients, navigating disputes, and contributing to informed public discourse.

This article provides a detailed overview of South Africa's current vaccination schedule, examines the underlying statutory and regulatory provisions, and assesses its alignment with international standards. Furthermore, it delves into contemporary legal issues, such as parental consent and the implications of vaccination policies for practitioners, offering insights into the evolving landscape of public health law in the country.

The legal foundation for South Africa's health system, including its vaccination programme, is primarily laid out in the National Health Act 61 of 2003. This Act provides a framework for a structured, uniform health system, emphasising the government's responsibility to provide health services and promote the health of the population. While the Act does not explicitly detail the vaccination schedule, it empowers the Minister of Health to prescribe conditions for health services and sets the stage for public health interventions.

Complementing the National Health Act is the Children's Act 38 of 2005, which is pivotal in defining parental responsibilities and rights concerning a child's health and well-being. This Act addresses the critical issue of consent to medical treatment for children, stipulating that children aged 12 or older may consent to medical treatment, including vaccination, provided they possess sufficient maturity to understand the benefits, risks, and implications. For children under 12, parental or guardian consent is generally required. The Act also provides mechanisms for judicial intervention in cases where parental refusal of medical treatment is deemed unreasonable and not in the child's best interests.

The Expanded Programme on Immunisation (EPI) in South Africa, launched as a unified national programme in 1995, has been instrumental in controlling and eliminating numerous infectious diseases. Historically, the programme has seen significant milestones, including the introduction of the Hepatitis B vaccine in 1995, Haemophilus influenzae type b (Hib) vaccine in 1999, pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RV) in 2009, and the human papillomavirus (HPV) vaccine for girls in 2014. More recently, South Africa became the first country in Africa to introduce a fully liquid hexavalent vaccine in 2015, and in 2024, it adopted recommendations for universal rubella vaccination, further enhancing its schedule.

South Africa's current Expanded Programme on Immunisation (EPI) schedule, updated and effective from January 2024, is designed to protect children from birth through 12 years of age against a range of life-threatening diseases. The schedule includes routine vaccinations for polio, tuberculosis (BCG), measles, pertussis (whooping cough), diphtheria, tetanus, hepatitis B, Haemophilus influenzae type b (Hib), pneumococcal disease (PCV), rotavirus (RV), rubella, and human papillomavirus (HPV) for girls. Vaccines are administered at specific ages, starting with BCG and Oral Polio Vaccine (OPV) at birth, followed by a series of combination vaccines (DTaP-IPV-Hib-HBV, PCV, RV) at 6, 10, and 14 weeks. Measles and Rubella vaccines are given at 6 and 12 months, while HPV vaccination targets Grade 5 girls at 9 years old, now with a single-dose strategy.

When measured against international standards, particularly those set by the World Health Organization (WHO), South Africa's EPI schedule is largely comprehensive. The country provides routine vaccination against twelve of the thirteen childhood illnesses targeted for universal vaccination by the WHO. The notable exception is the Respiratory Syncytial Virus (RSV) vaccine, which is not yet routinely provided in South Africa, despite its potential to prevent severe illness in infants. Other identified gaps include the lack of a universal birth dose vaccine against hepatitis B for all infants and maternal vaccines against RSV. While the public sector offers these vaccines free of charge, the private sector provides additional optional vaccines such as those for hepatitis A, mumps, chickenpox, meningococcal disease, and seasonal influenza, often at significant cost, as childhood vaccinations are not currently prescribed minimum benefits (PMBs) for medical schemes.

The legal landscape surrounding vaccination in South Africa, while generally supportive of public health initiatives, has seen increasing scrutiny, particularly concerning consent and potential mandatory policies. Although South Africa does not have a general mandatory vaccination schedule, the debate around mandatory COVID-19 vaccinations during the pandemic highlighted the legal complexities. Legal experts, such as Halton Cheadle, opined that mandatory workplace vaccination policies would likely withstand constitutional challenges, and Commission for Conciliation, Mediation and Arbitration (CCMA) rulings have, in some instances, upheld dismissals for refusal to vaccinate based on operational requirements.

Crucially, the Children's Act 38 of 2005 plays a significant role in determining a child's autonomy regarding medical treatment. Section 129 of the Act allows children aged 12 years or older to consent to medical treatment, including vaccination, provided they demonstrate sufficient maturity to understand the implications. This provision can create a legal dynamic where a child's decision may diverge from parental wishes. In instances of parental disagreement or unreasonable refusal of vaccination for a child, the courts, particularly the High Court or Children's Court, have the power to intervene and grant consent, prioritising the child's best interests. This legal mechanism underscores the state's ultimate role in safeguarding children's health. A significant concern, however, is the observed decline in vaccination rates, with only 75.1% of children receiving all recommended vaccines by their first birthday in 2024/2025, a decrease from 83% five years prior, which poses a substantial public health risk.

South Africa's Expanded Programme on Immunisation stands as a commendable public health achievement, offering a comprehensive suite of vaccines that largely aligns with global recommendations. The robust legal framework, primarily anchored in the National Health Act 61 of 2003 and the Children's Act 38 of 2005, provides the necessary authority and guidance for its implementation, while also addressing the nuanced aspects of consent and individual rights. The ongoing evolution of the schedule, as evidenced by recent additions like rubella vaccination and the updated HPV strategy, demonstrates a proactive approach to disease prevention.

For legal practitioners, the implications are multifaceted. Advising clients on parental rights and responsibilities regarding childhood vaccinations, particularly in cases of disagreement or refusal, requires a thorough understanding of the Children's Act and the courts' emphasis on the child's best interests. Furthermore, the precedents set during the COVID-19 pandemic regarding mandatory vaccination policies in workplaces remain relevant for future public health crises, necessitating careful consideration of constitutional rights against public health imperatives. The concerning trend of falling vaccination rates, as highlighted by recent data, presents a critical challenge that may lead to increased legal and ethical dilemmas, potentially prompting further policy interventions. Practitioners should remain vigilant of developments in public health policy and case law, as the balance between individual autonomy and collective health continues to be a dynamic area of law.